FDA-approved Drug Labeling [clinicaltrials_resource:88d375faadfa5126ab3c17239aabf26a]
Pegfilgrastim as Support to Advanced Breast Cancer Patients Receiving Chemotherapy [clinicaltrials:NCT00035594]Pegfilgrastim as Support to Pediatric Sarcoma Patients Receiving Chemotherapy [clinicaltrials:NCT00035620]clinicaltrials:NCT00094809Pegfilgrastim Given Same Day As or Day After Carboplatin and Docetaxel in Advanced Metastatic Non-Small Cell Lung Cancer (NSCLC) [clinicaltrials:NCT00094822]Evaluating Pegfilgrastim and a Multi-Day Topotecan Regimen in Subjects With Relapsed or Refractory Ovarian Cancer [clinicaltrials:NCT00113789]Pegfilgrastim Administered on the Same Day as Chemotherapy in Non-Hodgkin's Lymphoma [clinicaltrials:NCT00115193]Neulasta® in Subjects With Advanced Non-Small-Cell Lung Cancer (NSCLC) During Chemotherapy [clinicaltrials:NCT00115206]A Study of Carboplatin/Paclitaxel With Pegfilgrastim Supported by Haematopoietic Progenitor Cell Re-Infusion in Whole Blood [clinicaltrials:NCT00117442]A Study of Cyclophosphamide/Methotrexate/5-Fluorouracil (CMF) With Pegfilgrastim in Subjects With Breast Cancer [clinicaltrials:NCT00124111]
link [clinicaltrials_vocabulary:link]
FDA-approved Drug Labeling [clinicaltrials_resource:88d375faadfa5126ab3c17239aabf26a]
Bio2RDF identifier
88d375faadfa5126ab3c17239aabf26a
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:88d375faadfa5126ab3c17239aabf26a
url [clinicaltrials_vocabulary:url]
identifier
clinicaltrials_resource:88d375faadfa5126ab3c17239aabf26a
title
FDA-approved Drug Labeling
@en
type
label
FDA-approved Drug Labeling [clinicaltrials_resource:88d375faadfa5126ab3c17239aabf26a]
@en